VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024
August 03, 2023 at 10:00 pm EDT
Share
VITAL KSK HOLDINGS, INC. provided consolidated earnings guidance for the first half and full year of fiscal year ending March 31, 2024. For the first half, the company expects net sales of JPY 290,000 million, operating profit of JPY 2,400 million and profit attributable to owners of parent of JPY 2,000 million or JPY 39.07 per basic share.
For the full year, the company expects net sales of JPY 576,000 million, operating profit of JPY 4,700 million and profit attributable to owners of parent of JPY 5,200 million or JPY 101.57 per basic share.
VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.
VITAL KSK HOLDINGS, INC. 
